Singh, C. (2022) “High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings”, Acta Oncologica, 61(12), pp. 1512–1514. doi: 10.1080/0284186X.2022.2162347.